Fundraising Fox

Transcarent

Unicorn · $2.2B

Denver, US · Founded 2020 · 847 employees on LinkedIn · 18 known investors

Find your way into Transcarent

212 people in our graph share verified history with the Transcarent team — schools, employers, funds. One of them is your warm intro.

Chris Bischoffunlockedknows Glen Tullman · together at Livongo (overlapped)
×3knows the team · via Livongo
knows the team · via Transcarent
knows the team · via University of Oxford
×4knows the team · via 7wire Ventures
knows the team · via Bucknell University

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.

Also known as Transcarent, Inc.

Founders & leadership

Transcarent was founded in 2020 by Glen Tullman.

GTGlen Tullman
Glen Tullmanin𝕏Founder · Chief Executive OfficerHe previously served as founder, CEO, and executive chairman of Livongo, which he took public and later merged with Teladoc Health in the industry's largest healthcare merger, and held CEO roles at Allscripts and Enterprise Systems, both of which he took public.

Investors · 18

Also in the syndicate · 6

7wireVenturesIntermountain HealthcareJove Equity PartnersMemorial Hermann Health SystemNorthwell HealthRush University Medical Center

Funding

SEC filings, press & company announcements

$126M disclosed across 1 of 4 rounds · 2021–2024

Source: company announcements and press reports — follow each round's link for the claim.

Valuation · disclosed

Disclosed events
$2.2Bvaluation at Series DMay 2024
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Company profile

researched Aug 2026

Transcarent operates a health and care platform sold to self-insured employers and health plans that brings medical, pharmacy and third-party point solutions into a single member experience. Its central product is the WayFinding experience, described as a doctor-informed, generative AI-powered interface that answers benefits questions specific to a member's plan, provides clinical guidance through a combination of agentic AI, dedicated Health Guides and expert medical opinions, and delivers care, including 24/7 virtual primary care via chat or scheduled video visits. The company states that its AI supports licensed clinicians rather than replacing them.

Alongside WayFinding, Transcarent packages a set of "Care Experiences" for higher-cost or complex needs: Pharmacy Care, Weight Health, Surgery Care (including surgery, muscle and joint care and Centers of Excellence), Cancer Care, and 2nd.MD expert second opinions. The consumer-facing mobile app lets members view a digital insurance card, search in-network clinicians, receive personalized recommendations, message a live Health Guide, manage prescriptions and compare medication prices, and see the benefits available through their employer or health plan. A separate offering, the Experience Store, aggregates a partner ecosystem across categories such as musculoskeletal, cardiometabolic, pharmacy, mental health, gastrointestinal, Centers of Excellence, women's health and family building, LGBTQIA+ care, chronic kidney disease, wellness and financial health, payment integrity and specialty infusion, under one contract, one bill and unified eligibility and reporting.

At the time of its Series D announcement, the company described a platform spanning Everyday Care (including "Care in 60 Seconds"), Pharmacy Care, Surgery Care delivered through health systems, ambulatory providers and Centers of Excellence, Weight Health and end-to-end Cancer Care, and said more than 4.3 million people had access to Transcarent through an employer or health plan.

Business model

Transcarent sells to employers, plan sponsors, consultants, health plans and TPAs, which make the platform available to employees and members as a benefit; providers can also join its Centers of Excellence and direct care ecosystem. The company states it is aligned with those who pay for healthcare and takes accountability for results, offering at-risk pricing models and transparent impact reporting. At the time of the Series C announcement, it described a fully at-risk model that pays providers up front for care and partners with employers without up-front or per-employee-per-month (PEPM) fees, with most members receiving no bills and no responsibility for co-pays or co-insurance. Through the Experience Store, employers procure multiple partner solutions under one contract and one bill.

Employer- and health-plan-sponsored benefit contracts. The company has described at-risk pricing tied to outcomes, and at the Series C stage said it worked with employers without up-front or per-employee-per-month fees while paying providers up front for care; the Experience Store consolidates partner solutions into a single contract and bill.

Traction

More than 4.3 million people had access to Transcarent through an employer or health plan as of May 2024. The company reports double-digit increases in member engagement with point solutions and increased utilization of 10-20% versus point solutions alone. Named customers referenced include Pilot Company. Total funding raised was approximately $450 million at a stated $2.2 billion valuation as of the May 2024 Series D.

Latest developments

In October 2025 the company announced an expansion of the Experience Store with additional women's health options. Current site materials emphasize the WayFinding agentic AI experience spanning benefits navigation, clinical guidance and 24/7 virtual care delivery, and the Experience Store partner ecosystem across specialty benefit categories.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Positions itself as the "One Place for Health and Care" addressing employer "point solution fatigue" by consolidating fragmented benefits, and describes its Experience Store as connecting employers to a large partner ecosystem in health benefits. Investors in its funding rounds include health systems such as Northwell Health, Intermountain Healthcare, Rush University Medical Center and Memorial Hermann Health System.

Combines benefits navigation, clinical guidance and care delivery in a single experience, integrating medical, pharmacy and point solutions rather than operating as a standalone point solution; pairs generative/agentic AI with human Health Guides and clinicians; consolidates third-party benefit vendors under one contract, bill and reporting layer; and offers at-risk pricing aligned to outcomes.

Technology

A generative AI-powered, "doctor-informed" platform combining software, data science and human Health Guides. The WayFinding experience carries context across interactions to answer benefits questions, help schedule care, guide decisions and provide reminders, and supports agentic AI-driven navigation, clinical guidance and care delivery. The company says its AI supports rather than overrules licensed clinicians. The platform launches from existing employer eligibility files without new data feeds or complex integrations, and incorporates the 98point6 AI-powered virtual care technology acquired in 2023.

Go-to-market

Direct enterprise sales to employers, plan sponsors, health plans and TPAs, supported by demo requests on its website, plus distribution through benefits consultants. The company has also used channel partnerships, including Walmart's selection of Transcarent as its go-to-market solution for self-insured employers, and partnerships with health systems through a National Independent Provider Ecosystem. Members are reached via app activation tied to employer eligibility, with marketing focused on open enrollment periods.

Self-insured employers and plan sponsors, benefits consultants, health plans and TPAs, and the employees, members and their families who use the app; providers and health systems participate through the Centers of Excellence and direct care ecosystem.

Geography

United States-focused service delivery, with a mailing address at 4700 S. Syracuse Street, Suite 900, Denver, Colorado, and offices in Chicago (Illinois), Plymouth Meeting (Pennsylvania), Seattle (Washington), San Francisco (California), Prague (Czech Republic) and Vancouver (British Columbia). Earlier announcements were datelined Palo Alto, California (2022) and San Francisco, California (2024).

History

Transcarent's early funding rounds were led by General Catalyst and 7wireVentures. In its first year-plus of operation it built a leadership team and acquired and integrated BridgeHealth, a provider of surgical and value-based care serving over one million members, and announced Walmart's selection of Transcarent as its go-to-market solution for self-insured employers. A $200 million Series C led by Kinnevik and Human Capital closed in January 2022, bringing total funding to $298 million. Between the Series C and Series D the company launched Weight Health, Cancer, Behavioral Health and Pharmacy Care Experiences, expanded its value-based Surgery Centers of Excellence program, acquired and integrated the 98point6 AI-powered virtual care platform and care business (including the affiliated Transcarent Clinic) in 2023, and launched a National Independent Provider Ecosystem with 12 leading health systems. A $126 million Series D was announced in May 2024.

Risks & controversies

The company notes that reported outcomes may vary and depend on plan design, population, geography, engagement and participating providers.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Increased utilization vs point solutions alone across benefits programsJan 202510-20%
People with access to Transcarent through an employer or health planMay 20244,300,000 people
Total funding raised to dateMay 2024$450M
ValuationMay 2024$2.2B

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Founder mafia

5 people who came through Transcarent went on to found or lead other companies.

Competitors · 3

by search overlap

Companies competing with Transcarent for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 8

launches, deals, and filings
Oct 2025
Experience Store expansion adds women's health options

Transcarent announced an expansion of its Experience Store partner ecosystem with more options for women's health.

source ↗

May 2024
Transcarent raises $126 million Series D

Series D led by General Catalyst and 7wireVentures with new investors Geodesic Capital and Memorial Hermann Health System and support from existing investors; proceeds directed to AI capabilities, commercial growth and strategic growth opportunities.

$126M source ↗

May 2024
Launch of National Independent Provider Ecosystem with 12 health systems

Transcarent launched a National Independent Provider Ecosystem with 12 leading health systems to deliver a high-quality consumer experience that is more affordable for self-insured employers.

source ↗

May 2024
Launch of Weight Health, Cancer, Behavioral Health and Pharmacy Care Experiences

Since the January 2022 Series C, Transcarent launched comprehensive Weight Health, Cancer, Behavioral Health and Pharmacy Care Experiences and grew its value-based Surgery Centers of Excellence program.

source ↗

Jan 2023
Acquisition and integration of 98point6 virtual care platform and care business

Transcarent completed the acquisition and integration of the 98point6 AI-powered virtual care platform and care business, including the affiliated Transcarent Clinic.

source ↗

Jan 2022
Transcarent raises $200 million Series C

Series C led by Kinnevik and Human Capital with participation from Ally Bridge Group, health systems Northwell Health, Intermountain Healthcare and Rush University Medical Center, and existing investors.

$200M source ↗

Jan 2022
Acquisition and integration of BridgeHealth

Transcarent completed the acquisition and integration of BridgeHealth, a provider of surgical and value-based care serving over one million members, as reported in the January 2022 Series C announcement.

source ↗

Jan 2022
Walmart selects Transcarent as go-to-market solution for self-insured employers

Walmart selected Transcarent as its go-to-market solution for self-insured employers, working together to give self-insured employers and employees access to Walmart services including everyday low-cost pharmaceutical pricing.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Transcarent do?
Transcarent offers an AI-powered health and care platform that unifies medical, pharmacy and point-solution benefits for employers.
Who founded Transcarent?
Transcarent was founded by Glen Tullman in 2020.
Who are Transcarent's investors?
Transcarent's investors include 7wire Ventures, Corewell Health Ventures, General Catalyst, Geodesic Capital, GreatPoint Ventures, Human Capital, Kinnevik, Ally Bridge Group and 4 more.
How much funding has Transcarent raised?
Transcarent has disclosed $126M raised across 1 of its 4 known rounds.
Where is Transcarent headquartered?
Transcarent is headquartered in Denver, US.